Formycon AG (0W4N.L)

EUR 23.25

(0.22%)

Total Debt Summary of Formycon AG

  • Formycon AG's latest annual total debt in 2023 was 29.48 Million EUR , down -40.2% from previous year.
  • Formycon AG's latest quarterly total debt in 2024 Q2 was 10.86 Million EUR , down 0.0% from previous quarter.
  • Formycon AG reported annual total debt of 49.3 Million EUR in 2022, up 833.35% from previous year.
  • Formycon AG reported annual total debt of 5.28 Million EUR in 2021, up 6.06% from previous year.
  • Formycon AG reported quarterly total debt of 8.8 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Formycon AG reported quarterly total debt of 29.48 Million EUR for 2023 FY, down -40.2% from previous quarter.

Annual Total Debt Chart of Formycon AG (2023 - 2009)

Historical Annual Total Debt of Formycon AG (2023 - 2009)

Year Total Debt Total Debt Growth
2023 29.48 Million EUR -40.2%
2022 49.3 Million EUR 833.35%
2021 5.28 Million EUR 6.06%
2020 4.98 Million EUR 0.0%
2019 - EUR 0.0%
2018 - EUR -100.0%
2017 789.85 EUR 0.0%
2016 - EUR 0.0%
2015 - EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR -100.0%
2011 291 Thousand EUR 0.0%
2010 - EUR 0.0%
2009 - EUR 0.0%

Peer Total Debt Comparison of Formycon AG

Name Total Debt Total Debt Difference
Boiron SA 13.7 Million EUR -115.195%
Laboratorios Farmaceuticos Rovi, S.A. 46.63 Million EUR 36.773%
Vetoquinol SA 17.62 Million EUR -67.268%
Valneva SE 208.81 Million EUR 85.879%
AB Science S.A. 19.1 Million EUR -54.369%
Nanobiotix S.A. 45.48 Million EUR 35.171%
PHAXIAM Therapeutics S.A. 10.19 Million EUR -189.107%
Vivoryon Therapeutics N.V. 38 Thousand EUR -77494.737%
BioSenic S.A. 28.16 Million EUR -4.705%
ABIVAX Société Anonyme 55.46 Million EUR 46.838%